This invention provides a solid pharmaceutical composition comprising amorphous Compound I. A solid dispersion of the present invention also contains a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant. Compound I may be formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant.本發明係關於一種呈固態之醫藥組成物,其包括非晶形化合物I。本發明之固態分散體亦包括藥學上可接受之親水性聚合物及藥學上可接受之界面活性劑。化合物I可調配於非晶形固態分散體中,該固態分散體並包括一藥學上可接受之親水性聚合物及一藥學上可接受之較佳界面活性劑。
